Concepedia
Statistics
Publications
8
Citations
1.7K
H-Index
Active since
2004
Affiliations
Beth Israel Deaconess Medical Center(Current)
University of California, Irvine
Dana-Farber Cancer Institute
Hadassah Medical Center
Dana-Farber/Harvard Cancer Center
Amanda Youmans is an author at Beth Israel Deaconess Medical Center specializing in kidney cancer, renal cell carcinoma, and oncology.
Publications per year
2004–2020
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
Arnold H. Zea, Paulo C. Rodrı́guez, Michael B. Atkins et al. · Cancer Research · 2005 · 833 citations
Medicine, Immunology, Oncology +17
Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer
Michael B. Atkins, Meredith M. Regan, David F. McDermott et al. · Clinical Cancer Research · 2005 · 401 citations · Full text
Medicine, Oncology, Pathology +16
Histologic Predictors of Renal Cell Carcinoma Response to Interleukin-2-Based Therapy
Melissa P. Upton, Robert A. Parker, Amanda Youmans et al. · Journal of Immunotherapy · 2005 · 221 citations
Medicine, Oncology, Pathology +17
Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma
Daniel Cho, Sabina Signoretti, Sandra L. Dabora et al. · Clinical Genitourinary Cancer · 2007 · 178 citations
Medicine, Oncology, Pathology +15
Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy
Michael B. Atkins, David F. McDermott, Meredith M. Regan et al. · Journal of Clinical Oncology · 2004 · 28 citations
1–5 of 8